Global Osimertinib Market Growth 2025-2031

December 2025 | 82 pages | ID: G5EDA7B30D8EN
LP Information

Abstracts

The global Osimertinib market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Osimertinib is a medication used to treat non-small-cell lung carcinomas (NSCLC) with specific mutations. It is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells and may help to shrink tumors.

The future market trends of Osimertinib are expected to be positive, as the demand for effective medication for the management of lung cancer is increasing. Osimertinib is considered an effective alternative for the treatment of NSCLC with mutation, which is one of the most common types of cancer. Moreover, major market players are investing highly in research and development to improve the efficacy and safety of Osimertinib, as well as to expand its indications and applications.

LP Information, Inc. (LPI) ' newest research report, the “Osimertinib Industry Forecast” looks at past sales and reviews total world Osimertinib sales in 2024, providing a comprehensive analysis by region and market sector of projected Osimertinib sales for 2025 through 2031. With Osimertinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Osimertinib industry.

This Insight Report provides a comprehensive analysis of the global Osimertinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Osimertinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Osimertinib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Osimertinib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Osimertinib.

This report presents a comprehensive overview, market shares, and growth opportunities of Osimertinib market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 40mg*30 Tablets
• 80mg*30 Tablets
• 40mg*10 Tablets
• 80mg*10 Tablets

Segmentation by Application:

• Locally Advanced NSCLC
• Metastatic NSCLC
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• AstraZeneca
• Incepta Pharmaceuticals Limited
• Everest Pharmaceuticals
• Beacon Pharma
• Drug International

Key Questions Addressed in this Report

What is the 10-year outlook for the global Osimertinib market?

What factors are driving Osimertinib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Osimertinib market opportunities vary by end market size?

How does Osimertinib break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Osimertinib Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Osimertinib by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Osimertinib by Country/Region, 2020, 2024 & 2031
2.2 Osimertinib Segment by Type
  2.2.1 40mg*30 Tablets
  2.2.2 80mg*30 Tablets
  2.2.3 40mg*10 Tablets
  2.2.4 80mg*10 Tablets
2.3 Osimertinib Sales by Type
  2.3.1 Global Osimertinib Sales Market Share by Type (2020-2025)
  2.3.2 Global Osimertinib Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Osimertinib Sale Price by Type (2020-2025)
2.4 Osimertinib Segment by Application
  2.4.1 Locally Advanced NSCLC
  2.4.2 Metastatic NSCLC
  2.4.3 Others
2.5 Osimertinib Sales by Application
  2.5.1 Global Osimertinib Sale Market Share by Application (2020-2025)
  2.5.2 Global Osimertinib Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Osimertinib Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Osimertinib Breakdown Data by Company
  3.1.1 Global Osimertinib Annual Sales by Company (2020-2025)
  3.1.2 Global Osimertinib Sales Market Share by Company (2020-2025)
3.2 Global Osimertinib Annual Revenue by Company (2020-2025)
  3.2.1 Global Osimertinib Revenue by Company (2020-2025)
  3.2.2 Global Osimertinib Revenue Market Share by Company (2020-2025)
3.3 Global Osimertinib Sale Price by Company
3.4 Key Manufacturers Osimertinib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Osimertinib Product Location Distribution
  3.4.2 Players Osimertinib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR OSIMERTINIB BY GEOGRAPHIC REGION

4.1 World Historic Osimertinib Market Size by Geographic Region (2020-2025)
  4.1.1 Global Osimertinib Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Osimertinib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Osimertinib Market Size by Country/Region (2020-2025)
  4.2.1 Global Osimertinib Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Osimertinib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Osimertinib Sales Growth
4.4 APAC Osimertinib Sales Growth
4.5 Europe Osimertinib Sales Growth
4.6 Middle East & Africa Osimertinib Sales Growth

5 AMERICAS

5.1 Americas Osimertinib Sales by Country
  5.1.1 Americas Osimertinib Sales by Country (2020-2025)
  5.1.2 Americas Osimertinib Revenue by Country (2020-2025)
5.2 Americas Osimertinib Sales by Type (2020-2025)
5.3 Americas Osimertinib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Osimertinib Sales by Region
  6.1.1 APAC Osimertinib Sales by Region (2020-2025)
  6.1.2 APAC Osimertinib Revenue by Region (2020-2025)
6.2 APAC Osimertinib Sales by Type (2020-2025)
6.3 APAC Osimertinib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Osimertinib by Country
  7.1.1 Europe Osimertinib Sales by Country (2020-2025)
  7.1.2 Europe Osimertinib Revenue by Country (2020-2025)
7.2 Europe Osimertinib Sales by Type (2020-2025)
7.3 Europe Osimertinib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Osimertinib by Country
  8.1.1 Middle East & Africa Osimertinib Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Osimertinib Revenue by Country (2020-2025)
8.2 Middle East & Africa Osimertinib Sales by Type (2020-2025)
8.3 Middle East & Africa Osimertinib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Osimertinib
10.3 Manufacturing Process Analysis of Osimertinib
10.4 Industry Chain Structure of Osimertinib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Osimertinib Distributors
11.3 Osimertinib Customer

12 WORLD FORECAST REVIEW FOR OSIMERTINIB BY GEOGRAPHIC REGION

12.1 Global Osimertinib Market Size Forecast by Region
  12.1.1 Global Osimertinib Forecast by Region (2026-2031)
  12.1.2 Global Osimertinib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Osimertinib Forecast by Type (2026-2031)
12.7 Global Osimertinib Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 AstraZeneca
  13.1.1 AstraZeneca Company Information
  13.1.2 AstraZeneca Osimertinib Product Portfolios and Specifications
  13.1.3 AstraZeneca Osimertinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 AstraZeneca Main Business Overview
  13.1.5 AstraZeneca Latest Developments
13.2 Incepta Pharmaceuticals Limited
  13.2.1 Incepta Pharmaceuticals Limited Company Information
  13.2.2 Incepta Pharmaceuticals Limited Osimertinib Product Portfolios and Specifications
  13.2.3 Incepta Pharmaceuticals Limited Osimertinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Incepta Pharmaceuticals Limited Main Business Overview
  13.2.5 Incepta Pharmaceuticals Limited Latest Developments
13.3 Everest Pharmaceuticals
  13.3.1 Everest Pharmaceuticals Company Information
  13.3.2 Everest Pharmaceuticals Osimertinib Product Portfolios and Specifications
  13.3.3 Everest Pharmaceuticals Osimertinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Everest Pharmaceuticals Main Business Overview
  13.3.5 Everest Pharmaceuticals Latest Developments
13.4 Beacon Pharma
  13.4.1 Beacon Pharma Company Information
  13.4.2 Beacon Pharma Osimertinib Product Portfolios and Specifications
  13.4.3 Beacon Pharma Osimertinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Beacon Pharma Main Business Overview
  13.4.5 Beacon Pharma Latest Developments
13.5 Drug International
  13.5.1 Drug International Company Information
  13.5.2 Drug International Osimertinib Product Portfolios and Specifications
  13.5.3 Drug International Osimertinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Drug International Main Business Overview
  13.5.5 Drug International Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Osimertinib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Osimertinib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 40mg*30Tablets
Table 4. Major Players of 80mg*30Tablets
Table 5. Major Players of 40mg*10Tablets
Table 6. Major Players of 80mg*10Tablets
Table 7. Global Osimertinib Sales by Type (2020-2025) & (K Pcs)
Table 8. Global Osimertinib Sales Market Share by Type (2020-2025)
Table 9. Global Osimertinib Revenue by Type (2020-2025) & ($ million)
Table 10. Global Osimertinib Revenue Market Share by Type (2020-2025)
Table 11. Global Osimertinib Sale Price by Type (2020-2025) & (USD/Pcs)
Table 12. Global Osimertinib Sale by Application (2020-2025) & (K Pcs)
Table 13. Global Osimertinib Sale Market Share by Application (2020-2025)
Table 14. Global Osimertinib Revenue by Application (2020-2025) & ($ million)
Table 15. Global Osimertinib Revenue Market Share by Application (2020-2025)
Table 16. Global Osimertinib Sale Price by Application (2020-2025) & (USD/Pcs)
Table 17. Global Osimertinib Sales by Company (2020-2025) & (K Pcs)
Table 18. Global Osimertinib Sales Market Share by Company (2020-2025)
Table 19. Global Osimertinib Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Osimertinib Revenue Market Share by Company (2020-2025)
Table 21. Global Osimertinib Sale Price by Company (2020-2025) & (USD/Pcs)
Table 22. Key Manufacturers Osimertinib Producing Area Distribution and Sales Area
Table 23. Players Osimertinib Products Offered
Table 24. Osimertinib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Osimertinib Sales by Geographic Region (2020-2025) & (K Pcs)
Table 28. Global Osimertinib Sales Market Share Geographic Region (2020-2025)
Table 29. Global Osimertinib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Osimertinib Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Osimertinib Sales by Country/Region (2020-2025) & (K Pcs)
Table 32. Global Osimertinib Sales Market Share by Country/Region (2020-2025)
Table 33. Global Osimertinib Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Osimertinib Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Osimertinib Sales by Country (2020-2025) & (K Pcs)
Table 36. Americas Osimertinib Sales Market Share by Country (2020-2025)
Table 37. Americas Osimertinib Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Osimertinib Sales by Type (2020-2025) & (K Pcs)
Table 39. Americas Osimertinib Sales by Application (2020-2025) & (K Pcs)
Table 40. APAC Osimertinib Sales by Region (2020-2025) & (K Pcs)
Table 41. APAC Osimertinib Sales Market Share by Region (2020-2025)
Table 42. APAC Osimertinib Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Osimertinib Sales by Type (2020-2025) & (K Pcs)
Table 44. APAC Osimertinib Sales by Application (2020-2025) & (K Pcs)
Table 45. Europe Osimertinib Sales by Country (2020-2025) & (K Pcs)
Table 46. Europe Osimertinib Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Osimertinib Sales by Type (2020-2025) & (K Pcs)
Table 48. Europe Osimertinib Sales by Application (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Osimertinib Sales by Country (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Osimertinib Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Osimertinib Sales by Type (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Osimertinib Sales by Application (2020-2025) & (K Pcs)
Table 53. Key Market Drivers & Growth Opportunities of Osimertinib
Table 54. Key Market Challenges & Risks of Osimertinib
Table 55. Key Industry Trends of Osimertinib
Table 56. Osimertinib Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Osimertinib Distributors List
Table 59. Osimertinib Customer List
Table 60. Global Osimertinib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 61. Global Osimertinib Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Osimertinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 63. Americas Osimertinib Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Osimertinib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 65. APAC Osimertinib Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Osimertinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Europe Osimertinib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Osimertinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 69. Middle East & Africa Osimertinib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Osimertinib Sales Forecast by Type (2026-2031) & (K Pcs)
Table 71. Global Osimertinib Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Osimertinib Sales Forecast by Application (2026-2031) & (K Pcs)
Table 73. Global Osimertinib Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. AstraZeneca Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors
Table 75. AstraZeneca Osimertinib Product Portfolios and Specifications
Table 76. AstraZeneca Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 77. AstraZeneca Main Business
Table 78. AstraZeneca Latest Developments
Table 79. Incepta Pharmaceuticals Limited Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors
Table 80. Incepta Pharmaceuticals Limited Osimertinib Product Portfolios and Specifications
Table 81. Incepta Pharmaceuticals Limited Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 82. Incepta Pharmaceuticals Limited Main Business
Table 83. Incepta Pharmaceuticals Limited Latest Developments
Table 84. Everest Pharmaceuticals Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors
Table 85. Everest Pharmaceuticals Osimertinib Product Portfolios and Specifications
Table 86. Everest Pharmaceuticals Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 87. Everest Pharmaceuticals Main Business
Table 88. Everest Pharmaceuticals Latest Developments
Table 89. Beacon Pharma Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors
Table 90. Beacon Pharma Osimertinib Product Portfolios and Specifications
Table 91. Beacon Pharma Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 92. Beacon Pharma Main Business
Table 93. Beacon Pharma Latest Developments
Table 94. Drug International Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors
Table 95. Drug International Osimertinib Product Portfolios and Specifications
Table 96. Drug International Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 97. Drug International Main Business
Table 98. Drug International Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Osimertinib
Figure 2. Osimertinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Osimertinib Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Osimertinib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Osimertinib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Osimertinib Sales Market Share by Country/Region (2024)
Figure 10. Osimertinib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 40mg*30Tablets
Figure 12. Product Picture of 80mg*30Tablets
Figure 13. Product Picture of 40mg*10Tablets
Figure 14. Product Picture of 80mg*10Tablets
Figure 15. Global Osimertinib Sales Market Share by Type in 2025
Figure 16. Global Osimertinib Revenue Market Share by Type (2020-2025)
Figure 17. Osimertinib Consumed in Locally Advanced NSCLC
Figure 18. Global Osimertinib Market: Locally Advanced NSCLC (2020-2025) & (K Pcs)
Figure 19. Osimertinib Consumed in Metastatic NSCLC
Figure 20. Global Osimertinib Market: Metastatic NSCLC (2020-2025) & (K Pcs)
Figure 21. Osimertinib Consumed in Others
Figure 22. Global Osimertinib Market: Others (2020-2025) & (K Pcs)
Figure 23. Global Osimertinib Sale Market Share by Application (2024)
Figure 24. Global Osimertinib Revenue Market Share by Application in 2025
Figure 25. Osimertinib Sales by Company in 2025 (K Pcs)
Figure 26. Global Osimertinib Sales Market Share by Company in 2025
Figure 27. Osimertinib Revenue by Company in 2025 ($ millions)
Figure 28. Global Osimertinib Revenue Market Share by Company in 2025
Figure 29. Global Osimertinib Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Osimertinib Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Osimertinib Sales 2020-2025 (K Pcs)
Figure 32. Americas Osimertinib Revenue 2020-2025 ($ millions)
Figure 33. APAC Osimertinib Sales 2020-2025 (K Pcs)
Figure 34. APAC Osimertinib Revenue 2020-2025 ($ millions)
Figure 35. Europe Osimertinib Sales 2020-2025 (K Pcs)
Figure 36. Europe Osimertinib Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Osimertinib Sales 2020-2025 (K Pcs)
Figure 38. Middle East & Africa Osimertinib Revenue 2020-2025 ($ millions)
Figure 39. Americas Osimertinib Sales Market Share by Country in 2025
Figure 40. Americas Osimertinib Revenue Market Share by Country (2020-2025)
Figure 41. Americas Osimertinib Sales Market Share by Type (2020-2025)
Figure 42. Americas Osimertinib Sales Market Share by Application (2020-2025)
Figure 43. United States Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Osimertinib Sales Market Share by Region in 2025
Figure 48. APAC Osimertinib Revenue Market Share by Region (2020-2025)
Figure 49. APAC Osimertinib Sales Market Share by Type (2020-2025)
Figure 50. APAC Osimertinib Sales Market Share by Application (2020-2025)
Figure 51. China Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 55. India Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Osimertinib Sales Market Share by Country in 2025
Figure 59. Europe Osimertinib Revenue Market Share by Country (2020-2025)
Figure 60. Europe Osimertinib Sales Market Share by Type (2020-2025)
Figure 61. Europe Osimertinib Sales Market Share by Application (2020-2025)
Figure 62. Germany Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 63. France Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Osimertinib Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Osimertinib Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Osimertinib Sales Market Share by Application (2020-2025)
Figure 70. Egypt Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Osimertinib Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Osimertinib in 2025
Figure 76. Manufacturing Process Analysis of Osimertinib
Figure 77. Industry Chain Structure of Osimertinib
Figure 78. Channels of Distribution
Figure 79. Global Osimertinib Sales Market Forecast by Region (2026-2031)
Figure 80. Global Osimertinib Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Osimertinib Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Osimertinib Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Osimertinib Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Osimertinib Revenue Market Share Forecast by Application (2026-2031)